This article was originally published in The Rose Sheet
Executive SummaryThe International Sun Protection Factor (SPF) Test Method, which sets a basis for harmonized strategy for substantiating claims on sun protection products worldwide, will initially be implemented in the EU, Japan and South Africa, the European Cosmetic, Toiletry and Perfumery Association announces. The industries, represented by their respective trade associations and joined by the U.S., signed the agreement June 1. More countries are expected to join the agreement, Colipa notes. In the U.S., FDA prescribes a method that differs "slightly," but the U.S. industry "supports and promotes the international method as the appropriate standard that all regulatory frameworks should move towards," Colipa adds. The industries of the four countries also will promote the test method as a standard of the International Standards Organization. In light of the agreement, "consumers can be assured that the same high-quality testing standard has been applied regardless of the country where they buy the products and authorities will have a tool to control the substantiation of SPF claims made by companies," Colipa adds...
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.